Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,387,550
-
Share change
-
-505,710
-
Total reported value
-
$5,425,000
-
Price per share
-
$1.60
-
Number of holders
-
13
-
Value change
-
-$2,202,430
-
Number of buys
-
4
-
Number of sells
-
11
Institutional Holders of NOVUS THERAPEUTICS INC - COM (NVUS) as of Q4 2018
As of 31 Dec 2018,
NOVUS THERAPEUTICS INC - COM (NVUS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,387,550 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, National Asset Management, Inc., DEUTSCHE BANK AG\, Vanguard Group Inc, Sequoia Financial Advisors, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, and RAYMOND JAMES & ASSOCIATES.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.